...
首页> 外文期刊>International Journal of Biotechnology >The competitiveness of biotechnology in Japan
【24h】

The competitiveness of biotechnology in Japan

机译:日本生物技术的竞争力

获取原文
获取原文并翻译 | 示例

摘要

This paper examines the competitiveness of biotechnology in Japan with Porter's Diamond Model. Japan is an industrialized country markedly different from the ones in Western Europe and North America. Japan has shown a remarkable capacity for economic growth and the use and integration of technologies. Japan is developing its strength in biotechnology based on a strong traditional position in many classical biotechnology sectors such as food processing and bio-engineering in the fermentation industry. This background provides a solid foundation for the development of modern biotechnology. Based on secondary data such as government publications and independent reports, this paper looks at the strengths and weaknesses of biotechnology in Japan. We show here that the support from the Japanese government has played a major role in the development of biotechnology. The clear long term vision from the government shapes the goals of investors, managers and employees through various policies. The Japanesegovernment has also stimulated a growth in R&D in universities and research centres and which has led to a close collaboration between industry and academia. The contribution from private sectors is also enormous. About 80 percent of the R&D resources are sourced from individual companies. To study the whole picture of biotechnology in Japan, Porter's Diamond Model provides a good and thorough basis to dissect how the Japanese biotechnology industry acquires global competitiveness. Although Japan stilllags behind the USA in the area of biotechnology, the Japanese have been carrying out an extremely well coordinated effort to excel in this field. Japan will intensify her successful approaches learned from other industries to push ahead the developmentof biotechnology. It is conceivable that it will become more and more difficult for the Western counterparts to compete with this well organized and systematic Japanese approach in biotechnology.
机译:本文利用波特的钻石模型研究了日本生物技术的竞争力。日本是一个工业化国家,与西欧和北美的工业化国家明显不同。日本显示出了显着的经济增长能力以及技术的使用和集成。日本在许多传统生物技术领域(如发酵行业的食品加工和生物工程)中具有很强的传统地位,因此正在发展其在生物技术方面的实力。这一背景为现代生物技术的发展奠定了坚实的基础。基于政府出版物和独立报告等次要数据,本文着眼于日本生物技术的优势和劣势。我们在这里表明,日本政府的支持在生物技术的发展中发挥了重要作用。政府明确的长期愿景通过各种政策影响着投资者,经理和员工的目标。日本政府还刺激了大学和研究中心的R&D增长,并导致了工业界和学术界之间的密切合作。私营部门的贡献也很大。大约80%的研发资源来自各个公司。为了研究日本生物技术的整体情况,波特的钻石模型为剖析日本生物技术产业如何获得全球竞争力提供了良好而透彻的基础。尽管日本在生物技术领域仍落后于美国,但日本人一直在协调一致地努力以在该领域取得卓越成就。日本将加强从其他行业学到的成功方法,以推动生物技术的发展。可以想象,西方同行要与这种组织良好,系统的日本生物技术方法竞争将变得越来越困难。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号